Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Cardiothoracic and Vascular Anesthesia|June 25, 2013
Ultrasound destruction of air microemboli as a novel approach to brain protection in cardiac surgeryMax Nedelmann, Nadine Schleicher, Simone Doenges, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|September 30, 2023
Raman spectroscopy and Raman optical activity of blood plasma for differential diagnosis of gastrointestinal cancersKaterina Kralova, Ondrej Vrtelka, Marketa Fouskova, et al.Plos One|January 7, 2021
Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosisSona Frankova, Mariia Lunova, Halima Gottfriedova, et al.Journal of Inherited Metabolic Disease|December 6, 2011
Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptomsRadan Bruha, Libor Vitek, Zdenek Marecek, et al.Hepato-Gastroenterology|July 8, 2009
Double-blind randomized multicenter study comparing the efficacy and safety of 10-day to 5-day terlipressin treatment of bleeding esophageal varicesRadan Bruha, Zdenek Marecek, Vlastimil Prochazka, et al.Pharmaceuticals (Basel, Switzerland)|January 8, 2025
The Effect of Tacrine on Functional Response of the Lower Oesophageal Sphincter Assessed by Endoscopic Luminal Impedance Planimetry in Experimental PigsJan Bures, Martin Novak, Vera Radochova, et al.Journal of Hepatology|June 20, 2014
Sustained virological response with telaprevir in 1,078 patients with advanced hepatitis C: the international telaprevir access programMassimo Colombo, Simone Strasser, Christophe Moreno, et al.Plos One|September 24, 2015
Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or CirrhosisAntonia Lepida, Massimo Colombo, Inmaculada Fernandez, et al.Antiviral Therapy|February 8, 2014
Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitorDavid Nelson, Eric M Yoshida, Matthew S Paulson, et al.Journal of Hepatology|August 21, 2016
Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trialJan Sperl, Gabor Horvath, Waldemar Halota, et al.Pageof 3